Metraipolis › archive › dc_191cd2299b1d
Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer — Europe PMC PMID:41727313
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727313
- DOI
- 10.3389/fcell.2026.1661424
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T02:46:34.216Z
- SHA-256 of the archived text
277e2958e80421e0ef7c87a98561860eb104ef521ac6616016d56b62cc398b1d- Stable URL of this page
https://metraipolis.com/documento/dc_191cd2299b1d
How to cite
Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer — Europe PMC PMID:41727313 — Europe PMC (en), https://europepmc.org/article/MED/41727313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_191cd2299b1d (Metraipolis archive dc_191cd2299b1d, sha256 277e2958e80421e0ef7c87a98561860eb104ef521ac6616016d56b62cc398b1d)
BibTeX
@misc{dc191cd2299b1d,
title = {Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer — Europe PMC PMID:41727313},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727313},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_191cd2299b1d; sha256 277e2958e80421e0ef7c87a98561860eb104ef521ac6616016d56b62cc398b1d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727313. Agents can read the archived copy with the MCP tool read_document.